{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:28:41Z","timestamp":1783405721012,"version":"3.54.6"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T00:00:00Z","timestamp":1763856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Suppor from GSK"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-04127-1","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T09:10:17Z","timestamp":1763889017000},"page":"1683-1690","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Needs and opportunities for improvement in the management and monitoring of gynaecological cancer in Spain"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7166-9762","authenticated-orcid":false,"given":"Ainhoa","family":"Madariaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Cots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charo","family":"Hierro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Pilar","family":"Barretina-Ginesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadna","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Serena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Salcedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noelia","family":"Mari\u00e1tegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,23]]},"reference":[{"issue":"3","key":"4127_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"4127_CR2","doi-asserted-by":"publisher","first-page":"04155","DOI":"10.7189\/jogh.14.04155","volume":"14","author":"B Zhu","year":"2024","unstructured":"Zhu B, Gu H, Mao Z, Beeraka NM, Zhao X, Anand MP, et al. Global burden of gynaecological cancers in 2022 and projections to 2050. J Glob Health. 2024;14:04155.","journal-title":"J Glob Health"},{"key":"4127_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17132072","author":"E Zampaoglou","year":"2025","unstructured":"Zampaoglou E, Boureka E, Gounari E, Liasidi PN, Kalogiannidis I, Tsimtsiou Z, et al. Screening for cervical cancer: a comprehensive review of guidelines. Cancers (Basel). 2025. https:\/\/doi.org\/10.3390\/cancers17132072.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"4127_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3322\/caac.21557","volume":"69","author":"RA Smith","year":"2019","unstructured":"Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, et al. Cancer screening in the United States, 2019: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2019;69(3):184\u2013210. https:\/\/doi.org\/10.3322\/caac.21557.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"4127_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1080\/07347332.2011.599829","volume":"29","author":"OA Urbaniec","year":"2011","unstructured":"Urbaniec OA, Collins K, Denson LA, Whitford HS. Gynecological cancer survivors: assessment of psychological distress and unmet supportive care needs. J Psychosoc Oncol. 2011;29(5):534\u201351. https:\/\/doi.org\/10.1080\/07347332.2011.599829.","journal-title":"J Psychosoc Oncol"},{"key":"4127_CR6","doi-asserted-by":"publisher","first-page":"658.e1","DOI":"10.1016\/j.ajog.2021.06.071","volume":"225","author":"A Madariaga","year":"2021","unstructured":"Madariaga A, Bhat G, Wilson MK, Li X, Cyriac S, Bowering V, et al. Research biopsies in patients with gynecologic cancers: patient-reported outcomes, perceptions, and preferences. Am J Obstet Gynecol. 2021;225:658.e1\u2013658.e9.","journal-title":"Am J Obstet Gynecol"},{"key":"4127_CR7","first-page":"A328","volume":"31","author":"B J\u00f3nsd\u00f3ttir","year":"2021","unstructured":"J\u00f3nsd\u00f3ttir B, Wikman A, Sundstr\u00f6m Poromaa I, St\u00e5lberg K. Advanced gynecological cancer: quality of life one year after diagnosis. Int J Gynecol Cancer. 2021;31:A328\u20139.","journal-title":"Int J Gynecol Cancer"},{"key":"4127_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15225428","author":"H Woopen","year":"2023","unstructured":"Woopen H, Keller M, Zocholl D, Mittelstadt S, Barretina-Ginesta MP, Heinzelmann-Schwarz V, et al. Side effects from cancer therapies and perspective of 1044 long-term ovarian cancer survivors\u2014results of expression VI-Carolin meets HANNA-holistic analysis of long-term survival with ovarian cancer: the international NOGGO, ENGOT, and GCIG survey. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15225428.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"4127_CR9","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1136\/ijgc-2019-000567","volume":"29","author":"E Urkmez","year":"2019","unstructured":"Urkmez E, Andac-Jones E, Cibula D, Querleu D, Halaska MJ, Driak D, et al. Perceptions, expectations, and experiences of gynecological cancer patients: a pan-European ESGO-ENGAGe survey. Int J Gynecol Cancer. 2019;29(9):1425\u201330. https:\/\/doi.org\/10.1136\/ijgc-2019-000567.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"4127_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1136\/ijgc-2019-000983","volume":"31","author":"F Reid","year":"2021","unstructured":"Reid F, Bhatla N, Oza AM, Blank SV, Cohen R, Adams T, et al. The World Ovarian Cancer Coalition Every Woman Study: identifying challenges and opportunities to improve survival and quality of life. Int J Gynecol Cancer. 2021;31(2):238\u201344. https:\/\/doi.org\/10.1136\/ijgc-2019-000983.","journal-title":"Int J Gynecol Cancer"},{"key":"4127_CR11","volume-title":"Thematic analysis: a practical guide","author":"V Braun","year":"2021","unstructured":"Braun V, Clarke V. Thematic analysis: a practical guide. London: SAGE Publications; 2021. https:\/\/uk.sagepub.com\/en-gb\/eur\/thematic-analysis\/book248481"},{"key":"4127_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ygyno.2019.04.094","volume":"154","author":"F Reid","year":"2019","unstructured":"Reid F, Jones A. The world ovarian cancer coalition every woman study: identifying global and local challenges, and the opportunities to improve survival and quality of life for women no matter where they live. Gynecol Oncol. 2019;154:39\u201340.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"4127_CR13","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s00520-024-08483-6","volume":"32","author":"B Vega","year":"2024","unstructured":"Vega B, Desai R, Solk P, McKoy JM, Flores AM, Phillips SM, et al. Increasing physical activity among older adults with gynecologic cancers: a qualitative study. Support Care Cancer. 2024;32(5):282. https:\/\/doi.org\/10.1007\/s00520-024-08483-6.","journal-title":"Support Care Cancer"},{"key":"4127_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20043751","author":"L Membrilla-Beltran","year":"2023","unstructured":"Membrilla-Beltran L, Cardona D, Camara-Roca L, Aparicio-Mota A, Roman P, Rueda-Ruzafa L. Impact of cervical cancer on quality of life and sexuality in female survivors. Int J Environ Res Public Health. 2023. https:\/\/doi.org\/10.3390\/ijerph20043751.","journal-title":"Int J Environ Res Public Health"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04127-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-04127-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04127-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T09:52:53Z","timestamp":1776765173000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-04127-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,23]]},"references-count":14,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["4127"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-04127-1","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,23]]},"assertion":[{"value":"24 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AM declares honoraria from AZ, AbbVie, Daiichi Sankyo, Eisai, GSK, MSD, Pharma&, and PharmaMar. MPBG declares honoraria from Abbvie, AZ, Clovis, GSK, MSD, Pharma&, PharmaMar, and Regeneron. EG has received advisory\/consultancy honorarium from AstraZeneca-MSD, Clovis Oncology, GSK-Tesaro, PharmaMar, and Roche; has received speaker bureau\/expert testimony honorarium from AstraZeneca-MSD, PharmaMar, Roche, GSK-Tesaro, Clovis, and Eisai; and has received travel\/accommodation\/expenses from Roche, GSK-Tesaro, and Baxter. The remaining of authors have no COIs to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}